{
    "medicine_id": "722d2e9845bb341c7beccc02d92944731718ecb4",
    "platform_id": "DB05150",
    "metadata": {
        "name": "Yondelis 0 25 MG Injection powder for solution",
        "composition": "0 25 MG CAD106",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in alzheimer s disease",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "CAD106 can block the formation of beta amyloid plaques in the brain Since the formation of such plaques is considered a hallmark of the disease CAD106 may offer the potential to advance the treatment of Alzheimer s disease",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}